Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HAART-treated”

Showing 20 of 0 results

Not applicableStudy completedNCT01024556
What this trial is testing

Observational Study on Anti-Tat Immune Response in HIV-1-infected HAART-treated Adult Subjects

Who this might be right for
HIV Infection
Barbara Ensoli, MD 142
Not applicableStudy completedNCT01038401
What this trial is testing

Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 30
Post-approval studies (Phase 4)Study completedNCT00232908
What this trial is testing

QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection

Who this might be right for
HIV Infections
Hoffmann-La Roche 361
Post-approval studies (Phase 4)Study completedNCT00160849
What this trial is testing

Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral Suppression

Who this might be right for
HIV Infections
Universidade Federal do Rio de Janeiro 60
Post-approval studies (Phase 4)Study completedNCT00202228
What this trial is testing

Lactate Metabolism Study in HIV Infected Persons

Who this might be right for
HIV InfectionsAIDSLactic Acidosis+1 more
Queen's University 30
Testing effectiveness (Phase 2)Study completedNCT00102206
What this trial is testing

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Testing effectiveness (Phase 2)Study completedNCT00270556
What this trial is testing

Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART.

Who this might be right for
HIV
Gilead Sciences 100
Not applicableStudy completedNCT00002392
What this trial is testing

Thalidomide in HIV-Infected Patients Who Are Receiving HAART

Who this might be right for
HIV Infections
Rockefeller University 12
Not applicableStudy completedNCT00001899
What this trial is testing

Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 38
Testing effectiveness (Phase 2)Study completedNCT00362440
What this trial is testing

Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome

Who this might be right for
HIV Lipodystrophy
Beth Israel Deaconess Medical Center 9
Large-scale testing (Phase 3)WithdrawnNCT00089518
What this trial is testing

Optimal Treatment for Kidney Disease in HIV Infected Adults

Who this might be right for
HIV InfectionsKidney Disease
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00076518
What this trial is testing

The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV InfectionsHypertriglyceridemia
National Institute of Allergy and Infectious Diseases (NIAID) 100
Large-scale testing (Phase 3)UnknownNCT00005002
What this trial is testing

Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 688
Not applicableStudy completedNCT00043641
What this trial is testing

HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 73
Not applicableStudy completedNCT02614950
What this trial is testing

Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection

Who this might be right for
Acute HIV InfectionAntiretroviral Treatment Interruption
SEARCH Research Foundation 8
Post-approval studies (Phase 4)Study completedNCT00296153
What this trial is testing

Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment

Who this might be right for
Human Immunodeficiency VirusIschemic Heart Disease
Pronova BioPharma 51
Post-approval studies (Phase 4)Study completedNCT00234975
What this trial is testing

Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score

Who this might be right for
HIV Infection
AbbVie (prior sponsor, Abbott) 86
Testing effectiveness (Phase 2)Ended earlyNCT00294372
What this trial is testing

Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 36
Post-approval studies (Phase 4)Study completedNCT00106171
What this trial is testing

Anti-HIV Medications for People Recently Infected With HIV

Who this might be right for
HIV Infections
Johns Hopkins Bloomberg School of Public Health 113
Testing effectiveness (Phase 2)Study completedNCT01513135
What this trial is testing

A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers

Who this might be right for
HIV Infections
Barbara Ensoli, MD 200
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation